0.00Open7.89Pre Close0 Volume2 Open Interest72.00Strike Price0.00Turnover191.03%IV-0.22%PremiumDec 27, 2024Expiry Date8.07Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9929Delta0.0056Gamma9.95Leverage Ratio-0.1663Theta0.0004Rho9.88Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet